For the quarter ending 2026-03-31, EVH made $496,246K in revenue. -$26,632K in net income. Net profit margin of -5.37%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 496,246 | 490,438* | 479,533 | 444,328 |
| Cost of revenue | 412,472 | 677,496* | 379,759 | 343,943 |
| Selling, general and administrative expenses | 72,818 | 74,665* | 77,592 | 75,209 |
| Depreciation and amortization expenses | 21,555 | 45,717* | 23,615 | 23,141 |
| Loss on lease termination | 0 | -2,521* | 1,230 | 0 |
| (gain) loss on disposal of non-strategic assets | - | 3,717* | - | - |
| Right-of-use asset impairment | - | 0* | - | - |
| Goodwill impairment | - | 99,500* | - | - |
| Change in fair value of contingent consideration | 0 | 3,320* | -1,089 | 3,206 |
| Operating expenses | 506,845 | 899,501* | 478,647 | 445,499 |
| Operating loss | -10,599 | -409,063* | 886 | -1,171 |
| Interest income | 1,014 | 1,118* | 964 | 1,084 |
| Interest expense | 16,868 | 15,357* | 16,475 | 11,601 |
| Gain from equity method investees | -11 | -164* | 156 | 197 |
| Loss on extinguishment/repayment of debt | - | -4,776* | 431 | - |
| Loss on option exercise | 0 | -52,250* | 0 | -196 |
| Extinguishment of series a preferred stock and other refinancing fees | - | -7,500* | 6,000 | 9,000 |
| Change in tax receivables agreement liability | - | -804* | 0 | 0 |
| Other income (expense), net | 742 | 182* | 80 | -35 |
| Loss before income taxes | -25,722 | -473,615* | -19,958 | -20,722 |
| Provision for income taxes | 910 | -247* | 906 | -825 |
| Income (loss) before preferred dividends and accretion of series a preferred stock | -26,632 | -473,368* | -20,864 | -19,897 |
| Dividends and accretion of series a preferred stock | 0 | -10,997* | 6,066 | 31,193 |
| Net loss attributable to common shareholders of evolent health, inc. - diluted | -26,632 | -462,371 | -26,930 | -51,090 |
| Basic EPS | -0.24 | -4.104 | -0.24 | -0.44 |
| Diluted EPS | -0.24 | -4.104 | -0.24 | -0.44 |
| Basic Average Shares | 111,905,000 | 112,676,000 | 114,066,000 | 115,882,000 |
| Diluted Average Shares | 111,905,000 | 112,676,000 | 114,066,000 | 115,882,000 |
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)